A closely related protease, neprilysin-like endopeptidase (NEP2), also degrades Aβ peptides efficiently in the brain, albeit with a regional distribution more restricted than that of neprilysin, and its activity is reduced in AD patients compared to non-impaired individuals [114]. The gene discussed is MME; the disease is Alzheimer disease.